Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sweetenham

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|May 18, 2001
Trials in advanced Hodgkin's disease: asking the right questions at the right timeJ Sweetenham
Lancet (London, England)|March 19, 1988
Updated Kiel classificationG Mead, J Sweetenham
Chemico-Biological Interactions|December 1, 1978
Comparison of in vivo and in vitro binding of polycyclic hydrocarbons to DNAA Eastman, J Sweetenham, E Bresnick
British Journal of Cancer|April 1, 2004
Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?A Hackshaw, J Sweetenham, A Knight
Clinical Radiology|December 2, 1998
The imaging of Burkitt's and Burkitt-like lymphomaK A Johnson, K Tung, G Mead, et al.
Annals of Hematology|May 25, 2002
A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphomaJ Pellatt, J Sweetenham, R M Pickering, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfaD L Patrick, D D Gagnon, M J Zagari, et al.
British Journal of Haematology|October 23, 1997
Endothelial cell precursors are normal components of human umbilical cord bloodM Nieda, A Nicol, P Denning-Kendall, et al.
Clinical and Laboratory Haematology|May 3, 2000
Autologous stem cell transplantation for malignancy: a systematic review of the literatureS J Simnett, L A Stewart, J Sweetenham, et al.
British Journal of Haematology|August 12, 1999
Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.KJ Sweetenham, K Hieke, M Kerrigan, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|May 18, 2001
Trials in advanced Hodgkin's disease: asking the right questions at the right timeJ Sweetenham
Lancet (London, England)|March 19, 1988
Updated Kiel classificationG Mead, J Sweetenham
Chemico-Biological Interactions|December 1, 1978
Comparison of in vivo and in vitro binding of polycyclic hydrocarbons to DNAA Eastman, J Sweetenham, E Bresnick
British Journal of Cancer|April 1, 2004
Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?A Hackshaw, J Sweetenham, A Knight
Clinical Radiology|December 2, 1998
The imaging of Burkitt's and Burkitt-like lymphomaK A Johnson, K Tung, G Mead, et al.
Annals of Hematology|May 25, 2002
A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphomaJ Pellatt, J Sweetenham, R M Pickering, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfaD L Patrick, D D Gagnon, M J Zagari, et al.
British Journal of Haematology|October 23, 1997
Endothelial cell precursors are normal components of human umbilical cord bloodM Nieda, A Nicol, P Denning-Kendall, et al.
Clinical and Laboratory Haematology|May 3, 2000
Autologous stem cell transplantation for malignancy: a systematic review of the literatureS J Simnett, L A Stewart, J Sweetenham, et al.
British Journal of Haematology|August 12, 1999
Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.KJ Sweetenham, K Hieke, M Kerrigan, et al.
Pageof 3